Literature DB >> 24132443

Isolated paroxysmal dysarthria caused by a single demyelinating midbrain lesion.

Luca Codeluppi1, Guido Bigliardi, Annalisa Chiari, Stefano Meletti.   

Abstract

Paroxysmal dysarthria is an unusual condition characterised by brief episodes of dysarthria with the sudden onset and frequent recurrence. It has been mainly reported in multiple sclerosis and an association with midbrain lesions has been claimed; however, most of the reported patients had multiple brain alterations so it was difficult to associate this symptom with a specific lesion site. We illustrate the cases of two patients with an isolated demyelinating midbrain lesion presenting paroxysmal dysarthria as the only symptom; both participants had oligoclonal bands in the cerebrospinal fluid and an unremarkable follow-up. Both patients had benefit from carbamazepine treatment, similarly to previously reported cases. Our report confirms that a demyelinating midbrain lesion is sufficient to provoke paroxysmal dysarthria. It is noteworthy that an erroneous diagnosis of psychogenic disorders was initially made in both cases, highlighting the importance not to underestimate isolated paroxysmal symptoms in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24132443      PMCID: PMC3822091          DOI: 10.1136/bcr-2013-200777

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  13 in total

1.  Paroxysmal dysarthria and ataxia in multiple sclerosis; a report of 2 unusual cases.

Authors:  F ANDERMANN; J B COSGROVE; D LLOYD-SMITH; A M WALTERS
Journal:  Neurology       Date:  1959-04       Impact factor: 9.910

2.  Paroxysmal attacks in multiple sclerosis.

Authors:  P O Ostermann; C E Westerberg
Journal:  Brain       Date:  1975-06       Impact factor: 13.501

3.  Symptomatic paroxysmal dysarthria-ataxia in demyelinating diseases.

Authors:  Christophe Marcel; Mathieu Anheim; Constance Flamand-Rouvière; Françoise Heran; Pascal Masnou; Clotilde Boulay; Ivan Mari; Christine Tranchant; Emmanuel Roze
Journal:  J Neurol       Date:  2010-03-30       Impact factor: 4.849

4.  Lamotrigine therapy for paroxysmal dysarthria caused by multiple sclerosis: a case report.

Authors:  P Valentino; R Nisticò; D Pirritano; G Bilotti; F Del Giudice; M Sturniolo; A Quattrone
Journal:  J Neurol       Date:  2011-01-25       Impact factor: 4.849

5.  [Paroxysmal dysarthria and ataxia. A pathognomonic seizure syndrome in multiple sclerosis (author's transl)].

Authors:  P Wolf; H Assmus
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

6.  Paroxysmal symptoms as the first manifestations of multiple sclerosis.

Authors:  J A Twomey; M L Espir
Journal:  J Neurol Neurosurg Psychiatry       Date:  1980-04       Impact factor: 10.154

7.  Paroxysmal dysarthria and ataxia in multiple sclerosis and corresponding magnetic resonance imaging findings.

Authors:  Yongmei Li; Chun Zeng; Tianyou Luo
Journal:  J Neurol       Date:  2010-09-18       Impact factor: 4.849

Review 8.  Primary episodic ataxias: diagnosis, pathogenesis and treatment.

Authors:  J C Jen; T D Graves; E J Hess; M G Hanna; R C Griggs; R W Baloh
Journal:  Brain       Date:  2007-06-15       Impact factor: 13.501

9.  Paroxysmal dysarthria and ataxia in a patient with Behçet's disease.

Authors:  F G Akman-Demir; M Eraksoy; I H Gürvit; G Saruhan-Direskeneli; O Aral
Journal:  J Neurol       Date:  1995-05       Impact factor: 4.849

10.  Paroxysmal dysarthria and ataxia after midbrain infarction.

Authors:  M Matsui; H Tomimoto; K Sano; K Hashikawa; H Fukuyama; H Shibasaki
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

View more
  2 in total

1.  Neuro-Behcet's disease presenting as solitary midbrain lesion with paroxysmal ataxia and dysarthria (PAD) case report.

Authors:  Abeer Sabry Safan; Ahmed El Beltagi; Ahmed El Sotouhy; Lina Yagan; Mohammed Abunaib; Gholam Adeli
Journal:  Clin Case Rep       Date:  2022-04-20

Review 2.  Isolated dysarthria as the sole manifestation of myasthenia gravis: a case report.

Authors:  Wei Li; Ling He; Xiaodong Jin; Li Li; Congcong Sun; Cuilan Wang
Journal:  J Int Med Res       Date:  2022-07       Impact factor: 1.573

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.